文献速递肝病

氨清除可预防实验性非酒精性脂肪肝纤维化进展

Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Hepatology · 2019-10-15

在NAFLD啮齿动物模型中,尿素循环酶表达与活性进行性下降导致高氨血症,伴随肝星状细胞活化和纤维化进展;用鸟氨酸苯乙酸盐降低氨水平可预防肝细胞死亡并显著减少纤维化,提示降氨是NAFLD的潜在治疗方向。

要点

  • NAFLD早期即可出现肝脏和全身性高氨血症,与尿素合成减少有关。
  • 高脂高胆固醇饮食啮齿动物模型中尿素循环酶进行性下降,伴随高氨血症和纤维化进展。
  • 氨清除剂鸟氨酸苯乙酸盐降低氨水平,可预防肝细胞死亡并显著减少纤维化。

核心结论

  • 肝脂肪变导致高氨血症,后者与肝纤维化进展相关;降低氨水平可预防纤维化进展,为NAFLD提供潜在治疗。

研究设计与样本

  • 研究采用高脂高胆固醇饮食诱导的NAFLD啮齿动物模型,并结合原代培养肝细胞和 precision-cut 肝切片进行体外实验。

主要发现

  • 在NAFLD啮齿动物模型中观察到尿素循环酶表达和活性进行性阶梯式下降,导致高氨血症、肝星状细胞活化证据和进行性纤维化。
  • 在原代培养肝细胞和 precision-cut 肝切片中,脂质和/或氨暴露后促纤维化标志物基因表达增加。
  • 用氨清除剂鸟氨酸苯乙酸盐降低氨水平,可预防肝细胞死亡,并在肝切片体外实验和啮齿动物模型体内均显著减少纤维化发展。
  • 啮齿动物模型中纤维化的预防与尿素循环酶活性和功能恢复、肝脏氨降低及炎症标志物减少相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: In nonalcoholic fatty liver disease (NAFLD), fibrosis is the most important factor contributing to NAFLD-associated morbidity and mortality. Prevention of progression and reduction in fibrosis are the main aims of treatment. Even in early stages of NAFLD, hepatic and systemic hyperammonemia is evident. This is due to reduced urea synthesis; and as ammonia is known to activate hepatic stellate cells, we hypothesized that ammonia may be involved in the progression of fibrosis in NAFLD. APPROACH AND RESULTS: In a high-fat, high-cholesterol diet-induced rodent model of NAFLD, we observed a progressive stepwise reduction in the expression and activity of urea cycle enzymes resulting in hyperammonemia, evidence of hepatic stellate cell activation, and progressive fibrosis. In primary, cultured hepatocytes and precision-cut liver slices we demonstrated increased gene expression of profibrogenic markers after lipid and/or ammonia exposure. Lowering of ammonia with the ammonia scavenger ornithine phenylacetate prevented hepatocyte cell death and significantly reduced the development of fibrosis both in vitro in the liver slices and in vivo in a rodent model. The prevention of fibrosis in the rodent model was associated with restoration of urea cycle enzyme activity and function, reduced hepatic ammonia, and markers of inflammation. CONCLUSIONS: The results of this study suggest that hepatic steatosis results in hyperammonemia, which is associated with progression of hepatic fibrosis. Reduction of ammonia levels prevented progression of fibrosis, providing a potential treatment for NAFLD.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. De Chiara F, Thomsen KL, Habtesion A, et al. Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease. Hepatology. 2019. PMID: 31378982. doi:10.1002/hep.30890

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。